A detailed history of Rhumbline Advisers transactions in Clover Health Investments, Corp. stock. As of the latest transaction made, Rhumbline Advisers holds 3,601 shares of CLOV stock, worth $11,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,601
Holding current value
$11,775
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.2 - $3.5 $4,321 - $12,603
3,601 New
3,601 $10,000
Q2 2023

Aug 08, 2023

SELL
$0.73 - $1.07 $337,399 - $494,544
-462,191 Reduced 96.4%
17,242 $15,000
Q1 2023

May 11, 2023

BUY
$0.82 - $1.34 $13,693 - $22,376
16,699 Added 3.61%
479,433 $405,000
Q4 2022

Feb 14, 2023

BUY
$0.87 - $1.86 $10,151 - $21,702
11,668 Added 2.59%
462,734 $430,000
Q3 2022

Nov 10, 2022

BUY
$1.7 - $3.4 $63,920 - $127,840
37,600 Added 9.09%
451,066 $767,000
Q2 2022

Aug 11, 2022

BUY
$2.05 - $3.65 $847,605 - $1.51 Million
413,466 New
413,466 $885,000

Others Institutions Holding CLOV

About CLOVER HEALTH INVESTMENTS, CORP.


  • Ticker CLOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 383,248,000
  • Market Cap $1.25B
  • Description
  • Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health In...
More about CLOV
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.